MedTrace Logo

Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.

NCT00404287 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2019-06-07

No results posted yet for this study

Summary

Atherosclerosis and aortic stenosis share inflammatory etiopathogenic characteristics in common. We hypothesized that statins therapy would decrease inflammatory markers concentrations in patients with degenerative aortic stenosis and halt the haemodynamic progression of the disease.

Conditions

  • Aortic Valve Stenosis

Interventions

DRUG

Fluvastatin

Sponsors & Collaborators

  • AORTICA Group

    lead OTHER

Principal Investigators

  • Pedro L Sanchez, MD, PhD · Hospital Universitario Gregorio Marañón de Madrid

  • Candido Martin-Luengo, MD, PhD · University of Salamanca

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-01
Primary Completion
2014-11-01
Completion
2018-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00404287 on ClinicalTrials.gov